{"transactions":[{"id":926783,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer"}}],"security":"Common Stock","published_at":"2026-01-30T17:20:15.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":44977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":188346,"source":{"system":"sec-edgar","filing":"0001193125-26-032069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1519692/000119312526032069/ownership.xml","form_type":"4"}},{"id":1081887,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-07-24T20:29:28.000Z","date":"2025-07-22","kind":"grant","planned":false,"acquired":true,"shares":71429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The unvested stock options are convertible into approximately 71,429 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the \"Grant Date\"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date."}],"balance_after":155102,"derivative":{"exercise_price":15,"expiration_date":"2035-07-09","underlying":"Common Stock","underlying_shares":71429},"source":{"system":"sec-edgar","filing":"0000950170-25-098531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1519692/000095017025098531/ownership.xml","form_type":"4"}},{"id":1915666,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-21T21:53:14.000Z","date":"2023-04-20","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":14.02,"value":70100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.64 to $14.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26785,"source":{"system":"sec-edgar","filing":"0001519692-23-000012","document":"wf-form4_168211398207180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000012/wf-form4_168211398207180.xml","form_type":"4"}},{"id":1940292,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-24T00:04:57.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":346,"price":12.15,"value":4203.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":31785,"source":{"system":"sec-edgar","filing":"0001519692-23-000010","document":"wf-form4_167961628683110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000010/wf-form4_167961628683110.xml","form_type":"4"}},{"id":1940291,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-24T00:04:57.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":332,"price":12.64,"value":4196.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":32131,"source":{"system":"sec-edgar","filing":"0001519692-23-000010","document":"wf-form4_167961628683110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000010/wf-form4_167961628683110.xml","form_type":"4"}},{"id":1940290,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-24T00:04:57.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":326,"price":12.89,"value":4202.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":32463,"source":{"system":"sec-edgar","filing":"0001519692-23-000010","document":"wf-form4_167961628683110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000010/wf-form4_167961628683110.xml","form_type":"4"}},{"id":1943207,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:03:55.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":333,"price":12.61,"value":4199.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":32789,"source":{"system":"sec-edgar","filing":"0001519692-23-000008","document":"wf-form4_167943982457262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000008/wf-form4_167943982457262.xml","form_type":"4"}},{"id":1943206,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:03:55.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":316,"price":13.28,"value":4196.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":33122,"source":{"system":"sec-edgar","filing":"0001519692-23-000008","document":"wf-form4_167943982457262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000008/wf-form4_167943982457262.xml","form_type":"4"}},{"id":1947326,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-17T22:04:40.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":4462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service."}],"balance_after":13388,"derivative":{"underlying":"Common Stock","underlying_shares":4462},"source":{"system":"sec-edgar","filing":"0001519692-23-000006","document":"wf-form4_167909066577368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000006/wf-form4_167909066577368.xml","form_type":"4"}},{"id":1947325,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:04:40.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":5000,"price":13.44,"value":67200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.28 to $13.65. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":33438,"source":{"system":"sec-edgar","filing":"0001519692-23-000006","document":"wf-form4_167909066577368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000006/wf-form4_167909066577368.xml","form_type":"4"}},{"id":1947324,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:04:40.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":313,"price":13.43,"value":4203.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":38438,"source":{"system":"sec-edgar","filing":"0001519692-23-000006","document":"wf-form4_167909066577368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000006/wf-form4_167909066577368.xml","form_type":"4"}},{"id":1947323,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:04:40.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":4462,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")"}],"balance_after":38751,"source":{"system":"sec-edgar","filing":"0001519692-23-000006","document":"wf-form4_167909066577368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000006/wf-form4_167909066577368.xml","form_type":"4"}},{"id":1958973,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-11T00:24:27.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":27160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."}],"balance_after":27160,"derivative":{"underlying":"Common Stock","underlying_shares":27160},"source":{"system":"sec-edgar","filing":"0001209191-23-017998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123017998/doc4.xml","form_type":"4"}},{"id":1958972,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-11T00:24:27.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":40097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":40097,"derivative":{"exercise_price":15,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":40097},"source":{"system":"sec-edgar","filing":"0001209191-23-017998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123017998/doc4.xml","form_type":"4"}},{"id":2007943,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-17T21:58:53.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":5000,"price":15.12,"value":75600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.01 to $15.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34289,"source":{"system":"sec-edgar","filing":"0001519692-23-000004","document":"wf-form4_167667111042182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000004/wf-form4_167667111042182.xml","form_type":"4"}},{"id":2049827,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-20T23:44:12.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":5000,"price":14.56,"value":72800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.35 to $14.70. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":39289,"source":{"system":"sec-edgar","filing":"0001519692-23-000002","document":"wf-form4_167425823782385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969223000002/wf-form4_167425823782385.xml","form_type":"4"}},{"id":2083896,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-16T21:55:40.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":5000,"price":14.64,"value":73200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.50 to $14.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44289,"source":{"system":"sec-edgar","filing":"0001519692-22-000012","document":"wf-form4_167122772509088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000012/wf-form4_167122772509088.xml","form_type":"4"}},{"id":2110506,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-18T21:12:41.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":5000,"price":16.54,"value":82700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.22 to $16.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49289,"source":{"system":"sec-edgar","filing":"0001519692-22-000010","document":"wf-form4_166880594253223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000010/wf-form4_166880594253223.xml","form_type":"4"}},{"id":2130433,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-28T20:24:32.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":123,"price":16.62,"value":2044.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.58 to $16.77. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54289,"source":{"system":"sec-edgar","filing":"0001519692-22-000008","document":"wf-form4_166698865674038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000008/wf-form4_166698865674038.xml","form_type":"4"}},{"id":2130432,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-28T20:24:32.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":4877,"price":15.9,"value":77544.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.49 to $16.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54412,"source":{"system":"sec-edgar","filing":"0001519692-22-000008","document":"wf-form4_166698865674038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000008/wf-form4_166698865674038.xml","form_type":"4"}},{"id":2157485,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-16T20:33:03.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":5000,"price":16.03,"value":80150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.74 to $16.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":59289,"source":{"system":"sec-edgar","filing":"0001519692-22-000006","document":"wf-form4_166336036117534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000006/wf-form4_166336036117534.xml","form_type":"4"}},{"id":2178411,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-19T20:52:15.000Z","date":"2022-08-18","kind":"sale","acquired":false,"shares":5000,"price":16.3,"value":81500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.99 to $16.71. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 862 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021, and 1,111 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":64289,"source":{"system":"sec-edgar","filing":"0001519692-22-000004","document":"wf-form4_166094231301126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000004/wf-form4_166094231301126.xml","form_type":"4"}},{"id":2337805,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-11T21:04:40.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":17850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":17850,"derivative":{"underlying":"Common Stock","underlying_shares":17850},"source":{"system":"sec-edgar","filing":"0001519692-22-000002","document":"wf-form4_164703265817676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000002/wf-form4_164703265817676.xml","form_type":"4"}},{"id":2337804,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T21:04:40.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":60846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":60846,"derivative":{"exercise_price":19.59,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":60846},"source":{"system":"sec-edgar","filing":"0001519692-22-000002","document":"wf-form4_164703265817676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000151969222000002/wf-form4_164703265817676.xml","form_type":"4"}},{"id":2912426,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":68372,"kind":"person","name":"Greenstein Leonard M.","position":1,"cik":"0001519692","reported_name":"Greenstein Leonard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T21:58:58.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":40999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on January 7, 2022, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years."}],"balance_after":40999,"derivative":{"exercise_price":47.25,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":40999},"source":{"system":"sec-edgar","filing":"0001209191-21-002747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121002747/doc4.xml","form_type":"4"}}]}